中华实用儿科临床杂志
中華實用兒科臨床雜誌
중화실용인과림상잡지
Journal of Applied Clinical Pediatrics
2014年
7期
554-557
,共4页
高海军%陈光%王浩%温连芳%杨颐馨%王鹏辉
高海軍%陳光%王浩%溫連芳%楊頤馨%王鵬輝
고해군%진광%왕호%온련방%양이형%왕붕휘
小儿肝移植%门静脉狭窄%介入治疗%经皮血管成形术
小兒肝移植%門靜脈狹窄%介入治療%經皮血管成形術
소인간이식%문정맥협착%개입치료%경피혈관성형술
Pediatric liver transplantation%Portal vein stenosis%Interventional radiology%Percutaneous transluminal angiography
目的 探讨小儿肝移植术后门静脉狭窄(PVS)介入治疗的中长期结果及治疗意义.方法 回顾性分析2008年1月至2012年12月肝移植术后PVS 5例患儿资料,男3例,女2例;年龄7个月~8岁,中位年龄2岁10个月.患儿原发病:1例为Carolis病,4例为先天性胆道闭锁.患儿均采用球囊扩张治疗,对患儿临床资料、影像随访资料、介入治疗的并发症和预后等情况进行总结.结果 5例肝移植术后PVS患儿球囊扩张治疗均成功,成功率为100%.肝移植术后早期狭窄1例,发生于术后0.5个月,迟发性狭窄4例,发生于术后3 ~ 30个月.PVS部位均发生在门静脉吻合口部位,狭窄部位门静脉直径为(2.3 ±0.6) mm(1.2~3.0 mm),狭窄程度为70% ~ 95%.患儿均采用球囊扩张,球囊扩张后狭窄部位的直径为(9±1)mm(8~10 mm)(t=32.560,P<0.05).扩张前狭窄两端压力梯度为(11.0±3.2)mmHg(8~16 mmHg),扩张后狭窄两端压力梯度为(2.2±1.5) mmHg(0 ~ 4.0 mmHg)(t=8.242,P<0.05).术后随访10~ 66个月,患儿门静脉均通畅,通畅率为100%.结论 肝移植术后PVS的介入治疗是一种安全、有效的治疗方法,中长期随访结果通畅率高.
目的 探討小兒肝移植術後門靜脈狹窄(PVS)介入治療的中長期結果及治療意義.方法 迴顧性分析2008年1月至2012年12月肝移植術後PVS 5例患兒資料,男3例,女2例;年齡7箇月~8歲,中位年齡2歲10箇月.患兒原髮病:1例為Carolis病,4例為先天性膽道閉鎖.患兒均採用毬囊擴張治療,對患兒臨床資料、影像隨訪資料、介入治療的併髮癥和預後等情況進行總結.結果 5例肝移植術後PVS患兒毬囊擴張治療均成功,成功率為100%.肝移植術後早期狹窄1例,髮生于術後0.5箇月,遲髮性狹窄4例,髮生于術後3 ~ 30箇月.PVS部位均髮生在門靜脈吻閤口部位,狹窄部位門靜脈直徑為(2.3 ±0.6) mm(1.2~3.0 mm),狹窄程度為70% ~ 95%.患兒均採用毬囊擴張,毬囊擴張後狹窄部位的直徑為(9±1)mm(8~10 mm)(t=32.560,P<0.05).擴張前狹窄兩耑壓力梯度為(11.0±3.2)mmHg(8~16 mmHg),擴張後狹窄兩耑壓力梯度為(2.2±1.5) mmHg(0 ~ 4.0 mmHg)(t=8.242,P<0.05).術後隨訪10~ 66箇月,患兒門靜脈均通暢,通暢率為100%.結論 肝移植術後PVS的介入治療是一種安全、有效的治療方法,中長期隨訪結果通暢率高.
목적 탐토소인간이식술후문정맥협착(PVS)개입치료적중장기결과급치료의의.방법 회고성분석2008년1월지2012년12월간이식술후PVS 5례환인자료,남3례,녀2례;년령7개월~8세,중위년령2세10개월.환인원발병:1례위Carolis병,4례위선천성담도폐쇄.환인균채용구낭확장치료,대환인림상자료、영상수방자료、개입치료적병발증화예후등정황진행총결.결과 5례간이식술후PVS환인구낭확장치료균성공,성공솔위100%.간이식술후조기협착1례,발생우술후0.5개월,지발성협착4례,발생우술후3 ~ 30개월.PVS부위균발생재문정맥문합구부위,협착부위문정맥직경위(2.3 ±0.6) mm(1.2~3.0 mm),협착정도위70% ~ 95%.환인균채용구낭확장,구낭확장후협착부위적직경위(9±1)mm(8~10 mm)(t=32.560,P<0.05).확장전협착량단압력제도위(11.0±3.2)mmHg(8~16 mmHg),확장후협착량단압력제도위(2.2±1.5) mmHg(0 ~ 4.0 mmHg)(t=8.242,P<0.05).술후수방10~ 66개월,환인문정맥균통창,통창솔위100%.결론 간이식술후PVS적개입치료시일충안전、유효적치료방법,중장기수방결과통창솔고.
Objective To evaluate the medium and long-term therapeutic results of percutaneous transhepatic angioplasty for portal vein stenosis (PSV) following pediatric liver transplantation.Methods From Jan.2008 to Dec.2012,5 cases with PVS after pediatric liver transplantation received percutaneous transhepatic angioplasty.There were 3 male and 2 female cases ranging from 7 months to 8 year-old with the median age of 2 years and 10 months.The protopathy included 1 Carolis disease and 4 congenital biliary atresia.The therapeutic results were monitored by clinical follow-up and imaging examination.The clinical data,imaging examination and therapeutic results were analyzed.Results All interventions were performed successfully,and the treatment efficacy was 100%.One patient was diagnosed with earl-onset PVS at 0.5 month after liver transplantation.Four patients were diagnosed with late-onset PVS at 3-30 months after liver transplantation.The prestenotic portal venous average diameter was (2.3 ± 0.6) mm (1.2-3.0 mm),the degrees of stenosis were 70%-95%.The poststenotic portal venous average diameter was (9 ± 1) mm (8-10 mm) (t =32.560,P < 0.05).The prestenotic portal venous average pressure gradient was (11.0 ± 3.2) mmHg (8-16 mmHg),and the poststenotic portal venous pressure gradient was(2.2 ± 1.5) mmHg(0-4.0 mmHg) (t =8.242,P < 0.05).Postoperative follow-up was 10-66 months,the portal veins of all cases were patent,and patency rate was 100%.Conclusions Percutaneous transhepatic stent angioplasty is an effective and safe method for treatment of PVS following liver transplantation.Its medium and long-term patency rates are high.